JSM vs MRK · P/E 16, $5.23B cap vs P/E 33, rev $16.61B
Navient Corporation SR NT 6% 121543 (JSM) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Navient Corporation SR NT 6% 121543 (JSM) is a other company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
JSM does not have a complete income-statement cache yet.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
JSM currently screens at market cap $5.23B and trailing P/E 15.9. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the JSM and MRK stock pages for the full models.
Not investment advice.